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Abstract
Heroin administration alters the induction of nitric oxide, a molecule known to play a critical role in
immune function. Previous research has shown that these alterations can be conditioned to
environmental stimuli that have been associated with drug administration. Little is known about the
brain areas that mediate these effects; however, the basolateral amygdala (BLA) has been implicated
in the formation of stimulus-reward associations within models of drug abuse. The present study
sought to determine whether inactivation of the BLA would alter heroin's conditioned effects on the
expression of inducible nitric oxide synthase (iNOS) and the pro-inflammatory cytokines, TNF-α
and IL-1β, in the rat. The conditioning procedure involved repeated pairing of heroin with placement
into a standard conditioning chamber. To test the conditioned response, animals were returned to the
previously drug-paired environment six days after the final conditioning session. Prior to testing,
animals received intra-BLA microinfusions of a mixture of the GABA agonists, muscimol and
baclofen. Following removal from the chambers on test day, all animals received subcutaneous
lipopolysaccharide to induce systemic expression of iNOS, TNF-α and IL-1β. Analyses using real-
time RT-PCR indicated that inactivation of the BLA blocked the suppressive effect of heroin-
associated environmental stimuli on iNOS induction and on the expression of the pro-inflammatory
cytokines TNF-α and IL-1β in spleen and liver tissue. This study is important because it is the first
to demonstrate that heroin's conditioned effects on pro-inflammatory mediators require the
basolateral amygdala. These findings may have significant implications for the treatment of heroin
users.
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Introduction
Exposure to drug cues is one of the key contributing factors to relapse mainly because these
cues induce a wide variety of complex, classically conditioned physical and behavioral
responses (Unnithan et al 1992; Derbas et al 2001). There has been increasing evidence from
studies conducted on human subjects showing that drug-paired stimuli can cause intense
craving, feelings of being ‘high’ and altered neural activity in drug users (Sideroff & Jarvik
1980; Ehrman et al. 1992). Current research in the area of drug addiction has focused on the
critical task of reducing relapse by attempting to curb cue-induced drug seeking behavior,
however, it is also imperative to take into account the widespread effects these cues may have
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Research in our laboratory and others has shown that not only will administration of heroin
suppress a number of basic immune parameters but many of these suppressive effects on the
immune system may also be conditioned to environmental cues that predict drug availability.
For instance, rats re-exposed to a previously morphine–paired environment display alterations
in basic immune parameters similar to those seen upon actual morphine administration
including decreased mitogen responsiveness of lymphocytes, decreased NK cell activity and
suppressed IL-2 production (Coussons et al 1992; Saurer et al 2008). In line with these studies,
it has been shown that heroin administration results in a profound reduction in LPS-induced
nitric oxide expression (Lysle & How 2000) and this effect on nitric oxide may be conditioned
to environmental stimuli that predict drug availability (Lysle & Ijames, 2002). In addition to
effects on nitric oxide, there is evidence that opiate administration may also alter the production
of the pro-inflammatory cytokines, TNF-α and IL-1β (Chao et al 1993; Pacifici et al 2000).
Given the critical nature of these pro-inflammatory mediators in the initial response to infection
it is imperative that we understand how heroin and heroin related cues may alter their
effectiveness.
Little is known about the brain areas involved in these conditioned effects, however, the
basolateral amygdala (BLA) has been implicated in the formation of stimulus-reward
associations within models of drug abuse. For example, inactivation of the BLA blocks the
ability of drug cues to re-instate drug seeking in rats that had been previously taught to self-
administer cocaine (McLauglin & See 2003; Fuchs et al 2005). In a similar study, inactivation
of the BLA was shown to abolish cue-induced reinstatement of drug seeking in rats taught to
administer heroin (Fuchs & See 2002). The current experiment sought to establish the role of
the basolateral amygdala in the conditioned effects of heroin on nitric oxide by quantifying
iNOS expression in spleen and liver tissue following inactivation of the BLA. In addition,
IL-1β and TNF-α were measured in these same tissues to determine whether exposure to stimuli
previously paired with heroin would alter the expression of these cytokines and if inactivation
of the BLA would have an effect on these conditioned alterations.
Materials and Methods
Animals
Male Lewis rats, weighing 225-250 g, were purchased from Charles River Laboratories
(Raleigh, N.C., USA). Upon arrival, animals were housed individually in plastic cages in a
colony room with a reversed light-dark (12h) cycle maintained through artificial illumination.
Animals were allowed access to food and water ad libitum throughout the experiment except
for the time spent in the conditioning chambers when food and water were not available. All
animals were given a 2-week habituation period before the start of experimental manipulations
and were handled regularly during this time. All procedures described were approved by the
IACUC of the University of North Carolina at Chapel Hill and conformed to National Institutes
of Health (NIH) Guidelines on the Care and Use of Laboratory Animals.
Drug Administration
Heroin (diacetylmorphine) was obtained from NIDA (Bethesda, MD) and dissolved in 0.9 %
sterile saline. For all experiments, animals received a subcutaneous injection of heroin at a
dose 1 mg/kg immediately prior to placement in the conditioning chamber on each of the five
conditioning trial days. This dose was selected based on prior experiments in our laboratory
showing that a 1 mg/kg dose of heroin alters LPS-induced iNOS mRNA expression in spleen
and liver tissue and induces conditioning (Lysle & How, 2000; Lysle & Ijames, 2002;
Szczytkowski & Lysle, 2007).
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Animals were anesthetized with 0.35 ml intramuscular injections of 1:1 (vol/vol) ketamine
hydrochloride (100 mg/ml) mixed with xylazine (20 mg/ml) and placed into the stereotaxic
apparatus. Animals were implanted with 26-gauge bilateral guide cannula (Plastics One,
Roanoke, VA) directed towards the BLA (AP -2.5, ML±5.0, DV -6.6) or Caudate control region
(AP -2.4, ML±4.5, DV -4.0). Coordinates are expressed as millimeters from bregma (Paxinos
& Watson, 1986).
Animals were given a two week recovery period before the start of conditioning trials. On test
day, animals received bilateral intracranial injections (0.3 μl/side infused over 1 min) of saline
vehicle or a combination of GABA agonists, muscimol (0.03 nmol)/baclofen (0.3 nmol), 30
minutes prior to re-exposure to the conditioning chambers to determine whether the brain areas
inactivated are necessary for the conditioned alterations in pro-inflammatory mediators.
Injectors extended 2 mm beyond the tip of the cannula and were left in place for 1 minute after
the injection to allow for proper infusion.
Procedures
Acquisition of conditioned response—All animals received five 60-min training
sessions in which they were administered a subcutaneous injection of heroin (1 mg/kg) upon
placement into a standard conditioning chamber which served as the conditioned stimulus.
Training sessions were separated by 48 hours. The conditioning chambers (BRS/LVE, Laurel,
Md., USA) were contained in a room separate from the animal colony. Chambers were fitted
with a metal grid floor design and cedar bedding to create an environment distinct from that
of the home cage and to provide both olfactory and tactile cues for conditioning. All
conditioning took place during the dark phase of the light cycle and the conditioning chambers
were kept dark to minimize effects on circadian rhythms.
Testing of expression of conditioned response—The test day took place six days
following the final conditioning session. Thirty minutes prior to testing, two groups of animals
(Mus/Bac-BLA; Mus/Bac-Caud) received intra-BLA (or intra-caudate) microinfusions of the
combination of GABA agonists, muscimol and baclofen, to temporarily inactivate the BLA
(or caudate). Control animals received intra-BLA (or intra-caudate) microinfusions of saline
vehicle (Saline-BLA; Saline-Caud). To test the expression of the conditioned response, two
groups of animals were re-exposed to the conditioned stimulus (i.e.; the conditioning chambers)
without drug to determine whether the conditioned stimulus alone would induce alterations in
pro-inflammatory mediators. Animals re-exposed to the conditioning chambers on test day are
indicated in the figures as CS. The remaining animals (home cage, HC) were returned to the
home cage following microinfusions and served as controls. Experimental treatment of each
group is outlined in Table 1. After the 60-min re-exposure, the animals were removed from
the chambers and given a subcutaneous injection of LPS (1000 μg/kg) to induce iNOS
production in spleen and liver tissue. Home cage animals also received LPS at this time. Six
hours after LPS administration all animals were sacrificed and samples of spleen, liver and
blood were collected for analysis. The 6-hr timepoint was selected based on previous research
in our laboratory showing maximal iNOS induction at six hours following LPS administration
(Lysle & How, 2000).
Real Time RT-PCR
To determine iNOS expression, real time RT-PCR was performed on tissue samples from the
spleen and liver. Total RNA was extracted from a section of each of the tissues using TRI-
Reagent (Molecular Research Center, Cincinnati, OH), a modification of the original method
described by Chomczynski and Sacchi (1987). RNA was quantified spectrophotometrically
(GeneQuant II, Pharmacia-Biotech, Piscataway, NJ, USA). For the RT-PCR, reverse
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transcription is performed using Oligo(dT)18 primer and Moloney Murine Leukemia Virus-
Reverse transcriptase following the protocol of the Advantage RT-for-PCR Kit from Clontech
(Palo Alto, CA, USA).
PCR amplifications were performed using the Fast Start™ DNA Master SYBR Green I Real-
Time PCR Kit (Roche) and the LightCycler instrument (Roche). A master mix containing all
reaction components was prepared for all reactions, with each reaction using a 20 ml mix placed
in glass capillary tubes specifically designed for use in the LightCycler system. The PCR primer
set for iNOS, 5′-CCCTTCCGAAGTTTCTGGCAGCAGC-3′ and 5′-
GGGTGTCAGAGTCTTGTGCCTTTGG-3′ was synthesized by the Nucleic Acids Core
Facility (Lineberger Cancer Center, UNC-Chapel Hill). Copy numbers were generated from
an external standard curve. Amplifications were carried out for 40 cycles and curves showing
fluorescence at each cycle were determined by the computer software (Roche). Samples were
pre-incubated for 10 minutes at 95° C to activate the Fast-Start Taq DNA polymerase. The
cycle temperatures were 95, 60, and 72°C for the denaturing, annealing, and extending,
respectively. The cycle times were 15, 5, and 25 s for the denaturing, annealing, and extending,
respectively. Fluorescence level was determined at the end of the extending phase for each
cycle of PCR. The analysis of the fluorescence level in standards and samples over the course
of 40 cycles was used to derive the number of copies of the target molecule in each sample.
Additionally, assessments of housekeeping gene expression, cyclophilin, were made to assure
comparable quality of RNA among samples. The sequence of the cyclophilin primers was 5′-
CCAAGACTGAGTGGCT-3′ and 5′-AGATTACAGGGTATTGCG-3′. The data are
expressed as a copy number of iNOS (per 10ng cDNA) based on the standard curve using the
Lightcycler software (Roche). Furthermore, to confirm the nature of amplification product, a
melt curve analysis was conducted after the final PCR cycle. This analysis involved denaturing
the products by slowly heating them to 95°C, during which fluorescence is continuously
measured.
ELISA
For IL-1β and TNF-α protein determinations, protein was extracted from a section of each
tissue using freeze/thaw lysis in tris-buffer containing antiproteinases. Protein was quantified
spectrophotometrically (Bio-Tek, Model EL312 kinetic reader, Winooski, VT, USA) using
Bio-Rad protein dye. The BioSource International, Inc. (Carlsbad, CA) rat IL-1β and TNF-α
ELISA test kits were used to determine the levels of IL-1β or TNF-α protein in each tissue
sample. Briefly, samples and standards were added to microtiter wells coated with antibody
that recognizes IL-1β or TNF-α and incubated at room temperature. Wells were washed
extensively and then incubated with biotinylated antibody, followed by a second wash and then
incubation with Streptavidin-HRP. After the final washing, a chromagen substrate solution
was added which reacted with the bound enzyme to produce color. The color intensity
developed proportionally to the amount of IL-1β or TNF-α present in each sample. The enzyme
reaction was stopped after 30 minutes, and the absorbance at 450 nm was measured with a Bio-
Tek (Winooski, VT) Model EL312 kinetic reader. A standard curve was obtained by plotting
the absorbance versus the corresponding concentrations of the supplied standards.
Nitrite/Nitrate Assay
The level of nitrite/nitrate in plasma samples was assessed using the Greiss reagent assay.
Nitrate and nitrite are formed non-enzymatically when nitric oxide is exposed to oxygen, thus
plasma levels of these products indicate the level of nitric oxide production. Total nitrite/nitrate
levels was determined by the conversion of nitrate to nitrite utilizing nitrate reductase in the
presence of NADPH and flavin adenine dinucleotide, and then an assessment using Greiss
reagent. Briefly, 6 μl of plasma diluted in 44 μl of dH2O was incubated in the dark for 90-min
with 10 μl of nitrate reductase (1.0 unit/ml), 20 μl of a 0.31 M phosphate buffer (ph 7.5), 10
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μl of 0.86 mM NADPH (Sigma), and 10 μl of a 0.11 mM flavin adenine dinucleotide in
individual wells of a 96-well plate. Then, 200 ml of Greiss reagent consisting of a 1:1 (v/v)
solution 1% sulfanilamide in 5.0% phosphoric acid and 0.1% N-(1-napthyl) ethyl-enedamine
dihydrochloride in distilled water was added to the samples. The color developed for ten
minutes at room temperature after which the absorbance was determined using a
spectrophotometer set at 550 nm. All reactions were carried out in triplicate. The total
micromolar concentration of nitrite was determined for each sample based on a standard curve.
Recovery of nitrate was greater than 95% using this assay.
Statistical Analysis
Analysis of variance was performed on all data sets. When the overall ANOVA showed
significant effects, post hoc comparisons were made using Tukey's test to compare individual
treatment groups. All analyses were conducted with the level of significance set at p < 0.05.
Histology
To confirm proper cannula placement Alcian blue dye was infused via the cannula following
sacrifice. Brains were then extracted and post-fixed in a 4% paraformaldehyde solution.
Following fixation the brains were transferred to a 30% sucrose solution for cryoprotection
and then frozen at -80° C until further analysis. Coronal sections (50 μm) were taken and stained
with cresyl violet for verification of cannula placement. Animals with cannula placement
outside of the targeted region were removed from the analyses. Figure 1 shows a schematic
diagram illustrating the most ventral point of the injection cannula for each animal in the study.
Figure 2 is a representative photomicrograph showing the injection cannula tract to the BLA.
Results
Effects of BLA inactivation on conditioned heroin-induced suppression of nitric oxide
expression
The first study investigated whether inactivation of the BLA or caudate control region
immediately before testing (exposure to the previously drug-paired environment) would alter
the conditioned effects of heroin on nitric oxide production. Six days following the final
conditioning session, half of the animals were re-exposed to the previously heroin-paired
environment for 60 min (Conditioned Stimulus, CS) while the other half remained in the home
cage and served as control groups (Home Cage, HC). In order to temporarily inactivate the
brain regions under investigation, animals in the Mus/Bac-BLA and Mus/Bac-Caud groups
received microinfusions of the muscimol/baclofen combination directly into the BLA or
Caudate, respectively, 30 min prior to testing. The animals in the Saline-BLA and Saline-Caud
groups received microinfusions of saline into these same areas.
Figure 3A shows the results of each treatment on LPS-induced expression of iNOS mRNA in
the spleen and liver following inactivation of the BLA. Analysis of iNOS copy number in
spleen and liver revealed a significant main effect of treatment [F(4,15)=10.711, P<0.01; F
(4,15)=9.432, p<0.01]. Moreover, there was a significant difference in iNOS mRNA copy
number between the animals exposed to the conditioned stimulus on test day who had received
intra-BLA saline (CS, Saline-BLA) and the animals who remained in the home cage on test
day and received intra-BLA saline (HC, Saline-BLA). These differences were evident in both
tissues (p<0.05) which supports our earlier findings indicating that exposure to a previously
heroin-paired environment alters the expression of iNOS mRNA. Most importantly, there were
no significant differences between the HC, Saline-BLA group and the experimental group that
received intra-BLA microinjections of muscimol/baclofen before exposure to the conditioned
stimulus on test day (CS, Mus/Bac-BLA) demonstrating the ability of BLA inactivation to
reduce the conditioned response. Furthermore, there were no significant differences between
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the HC, Saline-BLA group and the group that received intra-BLA muscimol and baclofen but
remained in the home cage on test day (HC, Mus/Bac-BLA) indicating that these results are
specific to administration of drug and not due to ancillary effects of the microinjections. There
were also no differences found in expression of the housekeeping gene, cyclophilin, between
any of the groups indicating that the alterations in mRNA were specific for iNOS and not the
result of an overall reduction in RNA expression or production (data not shown).
Figure 3B also shows the effects of each treatment on LPS-induced expression of iNOS mRNA
in the spleen and liver following inactivation of the caudate control region. Analysis of iNOS
copy number in spleen and liver revealed a significant main effect of treatment [F(4,15)=6.458,
p<0.05; F(4,15)=6.868, p<0.01]. There was a significant difference between the CS, Saline-
Caud group and the HC, Saline-Caud group in both tissues (p<0.05) which is in agreement
with the data from our previous research. Most importantly, there was also found to be a
significant difference between the HC, Saline-Caud group and the experimental group that
received intra-caudate microinjections of muscimol/baclofen that was re-exposed to the
conditioned stimulus on test day (CS, Mus/Bac-Caud) indicating that this region is not involved
in the conditioned effects of heroin on iNOS mRNA expression (p<0.05). Furthermore, there
were no significant differences between the HC, Saline-Caud group and the HC, Mus/Bac-
Caud group indicating that these results are specific to administration of drug and not due to
ancillary effects of the microinjections.
The data in Figure 4 show the effects of BLA (A) or caudate control region (B) inactivation
on serum nitrite/nitrate levels. Nitrite and nitrate are byproducts of nitric oxide production and
levels of these markers serve as an indirect analysis of nitric oxide levels in the blood. For the
BLA inactivation experiment, examination of nitrite/nitrate levels in the serum revealed a
significant main effect of treatment [F(4,15)=13.939, p<0.01] and a significant difference
between the CS, Saline-BLA group and the HC, Saline-BLA group (p<0.05) indicating that
exposure to a previously heroin paired environment reduces the production of nitric oxide.
There were no significant differences between the HC, Saline-BLA group and the CS, Mus/
Bac-BLA group demonstrating that inactivation of the BLA reduces the conditioned effects of
heroin on nitric oxide. Taken together, these findings show that inactivation of the BLA will
reduce the conditioned effects of heroin on nitric oxide production.
For the caudate control region experiment, analysis of variance revealed a significant main
effect of treatment [F(4,15)=16.767, p<0.01] and a significant difference between both the CS,
Saline-Caud group and the HC, Saline-Caud group (p<0.01) and the CS, Mus/Bac-Caud group
and the HC, Saline-Caud group (p<0.01). These results indicate that exposure to a previously
heroin-paired environment reduces the production of nitric oxide and this effect is not
attenuated by inactivation of this region of the caudate.
Effects of BLA inactivation on conditioned heroin-induced suppression of pro-inflammatory
cytokines
Figure 5 shows that the suppressive effect of heroin on the pro-inflammatory cytokine,
IL-1β, can be conditioned to environmental stimuli and this conditioned effect is reduced by
inactivation of the BLA. This effect was evident at both the protein and mRNA level and in
both spleen and liver tissue. Analysis revealed a main effect of treatment on both mRNA and
protein levels in the spleen [F(4,15)=6.546, p<0.01; F(4,15)=38.871, p<0.01] and liver [F(4,15)
=7.993, p<0.01; F(4,15)=21.964, p<0.01]. In line with our previous experiments, the CS,
Saline-BLA group exhibited significantly lower levels of IL-1β mRNA and protein in both the
spleen and liver (p<0.05) as compared to the HC, Saline-BLA group. The CS, Mus/Bac-BLA
group was not significantly different from the HC, Saline-BLA group indicating that
inactivation of the BLA was able to reverse the conditioned effects of heroin on IL-1β mRNA
and protein expression.
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Figure 6 shows that the suppressive effect of heroin on the pro-inflammatory cytokine,
IL-1β, can be conditioned to environmental stimuli and this conditioned effect is not altered
by inactivation of the caudate control region. This effect was evident at both the protein and
mRNA level in the spleen and at the protein level in liver tissue. Since the time of tissue
collection was optimized for iNOS analysis it is not surprising that there is no significant effect
at this timepoint in liver IL-1β mRNA levels. Since the effect is evident at the protein level
this suggests that it might also have been present at the mRNA level at an earlier timepoint.
Analysis revealed a main effect of treatment on both mRNA and protein levels in the spleen
[F(4,15)=20.141, p<0.01; F(4,15)=21.585, p<0.01] and on protein in the liver [F(4,15)=7.993,
p<0.01]. In line with our previous experiments, the CS, Saline-Caud group exhibited
significantly lower levels of IL-1β mRNA and protein in the spleen and in protein in the liver
(p<0.05) as compared to the HC, Saline-Caud group. The CS, Mus/Bac-BLA group also
exhibited significantly lower IL-1β protein and mRNA (except for liver mRNA which shows
the same trend but is not significant) when compared with the HC, Saline-Caud group
indicating that inactivation of the caudate control region was not able to reverse the conditioned
effects of heroin on IL-1β mRNA and protein expression.
Figure 7 shows that the suppressive effect of heroin on the pro-inflammatory cytokine, TNF-
α, can also be conditioned to environmental stimuli and, again, this conditioned effect is
reduced by inactivation of the BLA. This effect was evident at both the protein and mRNA
level in the spleen and liver with the exception of TNF-α mRNA in the liver. As with IL-1β,
the lack of a significant effect in liver TNF-α mRNA is not surprising and the significance at
the protein level suggests that an effect may have been evident at an earlier timepoint. Analysis
revealed a main effect of treatment on both mRNA and protein levels in the spleen [F(4,15)
=6.946, p<0.01; F(4,15)=27.644, p<0.01] and on protein levels in the liver [F(4,15)=7.313,
p<0.01]. In line with our previous experiments, the CS, Saline-BLA group exhibited
significantly lower levels of TNF-α mRNA in the spleen (p<0.05) and significantly lower levels
of TNF-α protein in both the spleen and liver (p<0.05) when compared to the HC, Saline-BLA
group.
Figure 8 shows that the suppressive effect of heroin on the pro-inflammatory cytokine, TNF-
α, is not altered by inactivation of the caudate control region. The suppressive effect of
conditioning was evident at both the protein and mRNA level. Analysis revealed a main effect
of treatment on both mRNA and protein levels in the spleen [F(4,15)=7.605, p<0.01.; F(4,15)
=7.779, p<0.01] and liver [F(4,15)=11.494, p<0.01; F(4,15)=12.655, p<0.01]. In line with our
previous experiments, the CS, Saline-Caud group exhibited significantly lower levels of TNF-
α mRNA and protein in the spleen and in the liver when compared to the HC, Saline-Caud
group. Inactivation of the caudate control region had no effect on this suppression as the CS,
Mus/Bac-Caud group also showed significantly lower levels of TNF-α protein and mRNA as
compared to the HC, Saline-Caud group (p<0.05).
Discussion
Previous research in our laboratory has shown that exposure to a previously drug-paired
environment induces alterations in nitric oxide production similar to those observed upon actual
drug administration (Lysle & Ijames, 2002; Szczytkowski & Lysle, 2007). The data presented
here are the first to demonstrate that the suppressive effects of heroin on the pro-inflammatory
cytokines, TNF-α and IL1-β, may also be conditioned to environmental stimuli. Both
Interleukin-1 beta (IL-1β) and Tumor necrosis factor-alpha (TNF-α) are pro-inflammatory
cytokines involved in host defense. When secreted, both IL-1β and TNF-α have widespread
effects in the host including altering the thermoregulatory setting in the hypothalamus to
produce fever and increasing the expression of adhesion factors on endothelial cells to promote
the transmigration of leukocytes to sites of infection. In addition, it appears that both TNF-α
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and IL-1β are highly involved in LPS-induced septic shock. Rats with LPS-induced septic
shock exhibited a peak in TNF-α mRNA in plasma at one hour post-infection with levels
beginning to decline by two hours after LPS administration. Similarly, IL-1β peaked at one
hour post-LPS and gradually returned to baseline over nine hours (Lin et al, 2006). The samples
collected in this study were taken at 6 hours post-LPS injection to optimize for LPS-induced
nitric oxide production. The ability of these manipulations to detect a significant change in
IL-1β and TNF-α demonstrates the robustness of these effects. Furthermore, given the time
course of these effects the fact that some of the data failed to reveal significant differences
between treatment groups in levels of TNF-α or IL-1β mRNA in the liver is not surprising.
However, the significant reduction in TNF-α and IL-1β protein in liver tissue detected by the
ELISA suggests that mRNA levels for these cytokines may have been previously suppressed
in the group that was re-exposed to the conditioned stimulus on test day but may have
rebounded by the 6-hour timepoint at which they were analyzed.
Given the multifaceted and complex involvement of these cytokines, as well as nitric oxide,
in the initial immune response to infectious challenge it is essential to understand the
mechanisms and neural circuitry through which heroin's conditioned alterations of these pro-
inflammatory mediators are controlled. The results presented here provide the first evidence
that inactivation of the BLA can reduce or even eliminate the conditioned suppressive effects
of heroin on nitric oxide induction and on the expression of the pro-inflammatory cytokines,
TNF-α and IL-1β. This attenuation appears to encompass several organ systems as it is found
in both spleen and liver tissues as well as in serum levels of nitrite/nitrate. In addition, the
attenuation is apparent at both the mRNA and protein levels showing that the expression as
well as the production of these mediators is altered. The use of several control groups further
demonstrates that these results are specific to the manipulations used and not related to ancillary
effects of the conditioning or surgical procedures. Moreover, in order to ensure that these results
were specific to the BLA, a control experiment was conducted in which an area of the caudate
situated dorsal to the BLA was inactivated. The inactivation of this region of the caudate did
not produce an attenuation of the conditioned response demonstrating that the results are
specific to the BLA. These findings are consistent with prior investigations showing that
heroin-induced alterations in immune status may be conditioned to drug-paired stimuli (Lysle
& Ijames, 2002) and that these alterations are indeed a form of associative learning as they are
susceptible to both extinction and latent inhibition (Szczytkowski & Lysle, 2007). In these
previous investigations, animals received subcutaneous injections of heroin upon placement
in a distinctive environment. Upon re-exposure to that environment, in the absence of drug,
the subjects exhibited a reduction in nitric oxide production similar to what is observed with
heroin treatment. Repeated exposure to the distinctive environment without drug, either pre-
(latent inhibition) or post-conditioning (extinction) abolished this conditioned effect. The
present study extends these previous findings by showing that the basolateral amygdala, an
area known to be involved in associative learning processes, is required for the expression of
these conditioned effects.
These results suggest that there exists a neural circuit, of which the BLA is an integral
component, which mediates these conditioned alterations in immune measures. Given the
wealth of research showing the involvement of the BLA in conditioned responses, it is not
surprising that this area would be required for the expression of conditioned suppression of
pro-inflammatory mediators. Numerous investigators have demonstrated a role of the BLA in
associative learning. For example, lesions of the BLA block acquisition of classical eye blink
conditioning (Blankenship et al., 2005), inhibit conditioned fear responses to aversive stimuli
in rats (Lee et al., 2005), and block acquisition of the motivational value of an appetitive US
(Setlow et al., 2002). In addition, learning of an inhibitory avoidance task involves neuronal
activity within the BLA (Chang et al., 2005) as does olfactory fear conditioning (Sevelinges
et al., 2004) and conditioning of odorant attractiveness in female mice (Moncho-Bogani et al.,
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2005). Furthermore, the BLA has been implicated in the formation of new, and in the utilization
of already established, stimulus-reward associations within models of drug abuse. For example,
inactivation of the BLA inhibits the reacquisition of heroin seeking in a test of conditioned
place preference (Rizos et al., 2005). Similarly, it has been demonstrated that inactivation of
the BLA abolishes the expression of CS-induced reinstatement of heroin-seeking behavior in
rats (Fuchs & See, 2002). In addition, it has been shown that animals receiving morphine paired
with a distinct environment exhibit Fos protein expression, a marker of neural activation, within
both the BLA and the central nucleus of the amygdala during a test of conditioned place
preference (Harris & Ashton-Jones, 2003).
The exact mechanism through which conditioned drug cues exert their effects on pro-
inflammatory mediators remains unknown as does the means by which the BLA alters these
effects. Studies suggest that it is unlikely the BLA itself has a direct effect on immune
parameters as lesions and/or inactivation of this area do not seem to induce changes in immune
reactivity (Jurkowski et al 2001; Grijalva et al 1990). This is consistent with the data reported
here since inactivation of the BLA, by itself, did not alter the induction of pro-inflammatory
mediators. While the BLA may not directly alter immune parameters, previous work in our
laboratory and others has shown several brain areas to which the BLA is connected that have
direct effects on the immune system including the central amygdala and the nucleus accumbens.
For instance, Hayley et al (2002) reported increased monoamine utilization in the central
amygdala in response to systemic administration of TNF-a suggesting that this area of the
amygdala is sensitive to peripheral changes in cytokine production. In addition, research has
shown that systemic LPS administration induces c-fos expression in the central amygdala
(Rivest & LaFlamme, 1995; Sagar et al 1995; Tkacs & Li, 1999) and infusion of dopamine D1
agonists directly into this area results in increased Con-A stimulated splenocyte proliferation
(Nistico et al 1994; Caroleo et al 1998). The BLA sends extensive projections to the central
amygdala and the communication between these two areas is thought to create a circuit by
which many conditioned responses are mediated (Pare et al 1995; Royer et al 1999; Likhtik et
al 2008). Likewise, studies have shown that interactions between the BLA and the nucleus
accumbens may be necessary for the establishment and expression of some conditioned
responses including cocaine seeking induced by conditioned drug cues (Setlow et al, 2002; Di
Ciano & Everitt, 2004). In addition, infusion of dopamine D1 antagonists into the nucleus
accumbens shell blocks morphine-induced suppression of NK cell cytotoxicity while infusion
of a D1 agonist recreates this suppression (Saurer et al 2006). These data suggest that dopamine
activity within the nucleus accumbens is both necessary and sufficient for the induction of
immune alterations. Since inactivation of the BLA attenuates the conditioned effects of heroin
on pro-inflammatory mediators it is possible that information regarding the conditioned
stimulus is routed through the BLA to the nucleus accumbens and it is actually the nucleus
accumbens that directly influences immune alterations.
Considering the increased susceptibility to infection that occurs with opioid use it is possible
that the conditioned alterations in certain immune parameters that occur in response to exposure
to drug-paired cues might also compromise immune function and increase susceptibility to
disease. The host's initial response to an immune challenge is a complex and highly regulated
process. Some of the key mediators involved in the initial response to potential pathogens are
inducible nitric oxide, IL-1β, and TNF-α. Each of these immune system components is
responsible for numerous processes that together make up the response that is necessary to
combat infectious agents and to prepare the site of infection for repair and recovery. These
results are important, not only because they provide the first demonstration that the suppression
of pro-inflammatory cytokines can be conditioned to environmental stimuli paired with heroin
administration, but also because they demonstrate that the expression of the conditioned effects
of heroin on pro-inflammatory mediators require the basolateral amygdala. These effects and
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the brain areas that control them need to be factored into the comprehensive treatment of opiate
users.
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BLA injection cannula placement was verified by cresyl violet stained coronal sections.
Symbols in the diagram represent the most ventral point of the injection cannula for each animal
in the study based on the atlas of Paxinos and Watson (1998). AP coordinates indicate the
distance from bregma in mm. (CS, Saline-black circles; CS, Mus/Back-gray circles; HC,
Saline-black squares; HC, Mus/Bac-gray squares; n=4 per group)
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Representative photomicrograph showing the cannula tract and site of injection within the BLA
on a cresyl violet stained coronal section. The arrow indicates the most ventral point of the
injector cannula tract.
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Effect of treatments on LPS-induced expression of iNOS mRNA in the spleen and liver as
determined by real-time RT-PCR. Re-exposure to the previously heroin-paired environment
(CS, conditioned stimulus) reduced iNOS mRNA in both spleen and liver tissue and this
reduction was attenuated by inactivation of the BLA (A) but not affected by inactivation of the
caudate control region (B). Data are expressed as iNOS copy number per 10 ng cDNA based
on a standard curve using Roche LightCycler software. (*) Asterick indicates a significant
difference (p<0.05) from the HC (Home cage), Saline-BLA/Caud group.
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Effect of treatments on serum nitrite/nitrate levels as determined by the Greiss reagent assay.
Re-exposure to the previously heroin-paired environment (CS, conditioned stimulus) reduced
serum levels of nitrite/nitrate and this reduction was attenuated by inactivation of the BLA (A)
but not affected by inactivation of the caudate control region (B). The data are expressed as
the micromolar concentration of nitrite/nitrate. (*) Asterick indicates a significant difference
(p<0.05) from the HC (Home cage), Saline-BLA/Caud group.
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Effect of treatments on LPS-induced expression of IL-1β mRNA and protein in the spleen (A,
C) and liver (B, D) as determined by real-time RT-PCR. Re-exposure to the previously heroin-
paired environment (CS, conditioned stimulus) reduced IL-1β mRNA and protein in both
spleen and liver tissue and this reduction was attenuated by inactivation of the BLA. The RT-
PCR data (A, B) are expressed as IL-1β copy number per 10 ng cDNA based on a standard
curve using Roche LightCycler software. The ELISA data (C, D) are expressed as picograms
of protein per ml. (*) Asterick indicates a significant difference (p<0.05) from the HC (Home
cage), Saline-BLA group.
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Effect of treatments on LPS-induced expression of IL-1β mRNA and protein in the spleen (A,
C) and liver (B, D) as determined by real-time RT-PCR. Re-exposure to the previously heroin-
paired environment (CS, conditioned stimulus) reduced IL-1β mRNA and protein in the spleen
and IL-1β protein in liver tissue and this reduction was not altered by inactivation of the caudate
control region. The RT-PCR data (A, B) are expressed as IL-1β copy number per 10 ng cDNA
based on a standard curve using Roche LightCycler software. The ELISA data (C, D) are
expressed as picograms of protein per ml. (*) Asterick indicates a significant difference
(p<0.05) from the HC (Home cage), Saline-Caud group.
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Effect of treatments on LPS-induced expression of TNF-α mRNA and protein in the spleen
(A, C) and liver (B, D) as determined by real-time RT-PCR. Re-exposure to the previously
heroin-paired environment (CS, conditioned stimulus) reduced TNF-α mRNA and protein in
the spleen and TNF-a protein in liver tissue and this reduction was attenuated by inactivation
of the BLA. The RT-PCR data (A, B) are expressed as TNF-α copy number per 10 ng cDNA
based on a standard curve using Roche LightCycler software. The ELISA data (C, D) are
expressed as picograms of protein per ml. (*) Asterick indicates a significant difference
(p<0.05) from the HC (Home cage), Saline-BLA group.
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Effect of treatments on LPS-induced expression of TNF-α mRNA and protein in the spleen
(A, C) and liver (B, D) as determined by real-time RT-PCR. Re-exposure to the previously
heroin-paired environment (CS, conditioned stimulus) reduced TNF-α mRNA and protein in
both spleen and liver tissue and this reduction was not attenuated by inactivation of the caudate
control region. The RT-PCR data (A, B) are expressed as TNF-α copy number per 10 ng cDNA
based on a standard curve using Roche LightCycler software. The ELISA data (C, D) are
expressed as picograms of protein per ml. (*) Asterick indicates a significant difference
(p<0.05) from the HC (Home cage), Saline-Caud group.
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Table 1
Schematic representation of the behavioral and pharmacological manipulations employed for each treatment group.
Treatment groups by experiment
BLA: Days 1-9 Test Day (D15): BLA Microinfusion CS Exposure
HC Saline-BLA Conditioning Saline Home Cage
CS Saline-BLA Conditioning Saline CS Re-Exposure
HC Mus/Bac-BLA Conditioning Muscimol/Baclofen Home Cage
CS Mus/Bac-BLA Conditioning Muscimol/Baclofen CS Re-Exposure
Caudate: Days 1-9 Test Day (D15): Caudate Microinfusion CS Exposure
HC Saline-Caud Conditioning Saline Home Cage
CS Saline-Caud Conditioning Saline CS Re-Exposure
HC Mus/Bac-Caud Conditioning Muscimol/Baclofen Home Cage
CS Mus/Bac-Caud Conditioning Muscimol/Baclofen CS Re-Exposure
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